Global history of screening for congenital hypothyroidism
10.3760/cma.j.cn113903-20240419-00294
- VernacularTitle:先天性甲状腺功能减退症的全球筛查史
- Author:
Qiman LIU
1
;
Wenpei TANG
Author Information
1. 北京大学医学人文学院，北京 100191
- Keywords:
Congenital hypothyroidism;
Neonatal screening
- From:
Chinese Journal of Perinatal Medicine
2024;27(7):603-606
- CountryChina
- Language:Chinese
-
Abstract:
This article outlines the global history of newborn screening for congenital hypothyroidism (CH), starting from the spread of medical knowledge and technology across the world. It is believed that the inception of CH screening programs greatly benefited from research linking thyroid dysfunction and intellectual impairment in the late 19th century, coupled with the discovery of thyroxine in the early 20th century. By the early 1970s, Professor Jean H. Dussault in Quebec, Canada, had conducted the first large-scale newborn CH screening program. As CH screening technologies have developed and spread globally, China has made significant progress in this area. Since the initial efforts in the early 1980s, there has been substantial increase in the national screening rate in recent years. However, China still confronts challenges due to regional disparities.
